| # | Drug | Count |
|---|---|---|
| 0 | LEVOTHYROXINE SODIUM | 18 |
| 1 | ASPIRIN | 16 |
| 2 | ASPIRIN 325 MG | 16 |
| 3 | ASPIRIN 81 MG | 16 |
| 4 | AMLODIPINE BESYLATE | 12 |
| 5 | METHOTREXATE SODIUM | 11 |
| 6 | DIAZEPAM | 10 |
| 7 | DIAZEPAM ORAL | 10 |
| 8 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 10 |
| 9 | VALSARTAN | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIMIPRAMINE MALEATE | 4 | 0.0101 |
| 1 | ACETIC ACID | 1 | 0.0028 |
| 2 | HYDROQUINONE | 1 | 0.0017 |
| 3 | FLUVASTATIN SODIUM | 4 | 0.0009 |
| 4 | PERINDOPRIL ERBUMINE | 4 | 0.0007 |
| 5 | SAXAGLIPTIN | 1 | 0.0007 |
| 6 | PLERIXAFOR | 1 | 0.0007 |
| 7 | CALCITONIN SALMON | 2 | 0.0006 |
| 8 | OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE | 1 | 0.0005 |
| 9 | FOLLITROPIN ALFA | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 1 | Benzodiazepine [EPC] | 20 |
| 2 | Corticosteroid [EPC] | 17 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 16 |
| 4 | GLP-1 Receptor Agonist [EPC] | 15 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 13 |
| 6 | Vitamin C [EPC] | 13 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 12 |
| 8 | Alkylating Drug [EPC] | 11 |
| 9 | Proton Pump Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 1 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 2 | Calcitonin [EPC] | 2 | 0.0006 |
| 3 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 4 | Vitamin D2 Analog [EPC] | 2 | 0.0003 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 7 | Vitamin D Analog [EPC] | 2 | 0.0001 |
| 8 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 9 | Vitamin D3 Analog [EPC] | 2 | 0.0001 |